Liebman Leaves Roche for New Motorola Venture, UPenn Post | GenomeWeb

NEW YORK, Nov 27 – Noted bioinformaticist Michael Liebman has resigned as Roche Bioscience’s global director of bioinformatics to become chief scientific officer at Genmatics, a joint venture between Motorola and Medical Science Associates, and director of computational biology at the University of Pennsylvania Medical School.

Genmatics is a provider of products that integrate genomic, epidemiological, and clinical data to solve problems for the biopharmaceutical and healthcare industries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.